ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[이코노미스트] 국산 CAR-T 치료제로 한 걸음…큐로셀의 상업화 계획은[임상이몽]
2024/03/12
국산 CAR-T 치료제로 한 걸음…큐로셀의 상업화 계획은[임상이몽] (naver.com)
Prev
큐로셀, 차세대 CAR-T 치료제 ‘안발셀’ 임상시험 성공 발표
Next
[비즈워치] 국내 첫 CAR-T 개발 성큼…큐로셀, ‘넥스트 스텝’은
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
